Hepatitis: Tightening the grip on clearing HCV infection (Nature Clinical Practice Gastroenterology & Hepatology)

Targeting a host factor involved in cellular item of HCV could be a promising new approach in the treatment of HCV infection, according to new research published in Nature Biotechnology. A monoclonal antibody (mAb) specific for the tight junction protein claudin-1 (CLDN1) prevented and